Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Bai

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 18, 2017
Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomyBo Fan, Bin Hu, Qingmin Yuan, et al.
Journal of Biomolecular Screening|February 24, 2012
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasisZhiyong Ding, Peter German, Shanshan Bai, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 3, 2015
The PI3K/AKT Pathway and Renal Cell CarcinomaHuifang Guo, Peter German, Shanshan Bai, et al.
Environmental Research|August 15, 2024
Challenges and opportunities in commercializing whole-cell bioreporters in environmental applicationZefeng Huang, Williamson Gustave, Shanshan Bai, et al.
Environmental Research|December 5, 2024
Corrigendum to 'Challenges and opportunities in commercializing whole-cell bioreporters in environmental application' [Environ. Res. 262 (2024) 119801]Zefeng Huang, Williamson Gustave, Shanshan Bai, et al.
Frontiers in Pharmacology|February 13, 2025
Impact of finasteride on modulating the risk and clinical outcomes of bladder cancer: insights from a comprehensive meta-analysisAiling Yu, Zian Bai, Yijie Wang, et al.
Journal of Cellular and Molecular Medicine|May 28, 2020
CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of actionCheng Hu, Hongyan Xia, Shanshan Bai, et al.
Genome Biology|July 8, 2020
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencingNaveen Ramesh, Emi Sei, Pei Ching Tsai, et al.
Oncology Letters|August 28, 2019
5-Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinomaMengying Tong, Shuhang Gao, Wenjing Qi, et al.
Journal of Ethnopharmacology|May 7, 2026
Integrative multi-omics reveals that Pueraria thomsonii Radix alleviates dyslipidemia by remodeling gut microbiota and regulating arachidonic acid metabolismDaqian Yin, Meiqing Chen, Xiaofan Chen, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 18, 2017
Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomyBo Fan, Bin Hu, Qingmin Yuan, et al.
Journal of Biomolecular Screening|February 24, 2012
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasisZhiyong Ding, Peter German, Shanshan Bai, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 3, 2015
The PI3K/AKT Pathway and Renal Cell CarcinomaHuifang Guo, Peter German, Shanshan Bai, et al.
Environmental Research|August 15, 2024
Challenges and opportunities in commercializing whole-cell bioreporters in environmental applicationZefeng Huang, Williamson Gustave, Shanshan Bai, et al.
Environmental Research|December 5, 2024
Corrigendum to 'Challenges and opportunities in commercializing whole-cell bioreporters in environmental application' [Environ. Res. 262 (2024) 119801]Zefeng Huang, Williamson Gustave, Shanshan Bai, et al.
Frontiers in Pharmacology|February 13, 2025
Impact of finasteride on modulating the risk and clinical outcomes of bladder cancer: insights from a comprehensive meta-analysisAiling Yu, Zian Bai, Yijie Wang, et al.
Journal of Cellular and Molecular Medicine|May 28, 2020
CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of actionCheng Hu, Hongyan Xia, Shanshan Bai, et al.
Genome Biology|July 8, 2020
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencingNaveen Ramesh, Emi Sei, Pei Ching Tsai, et al.
Oncology Letters|August 28, 2019
5-Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinomaMengying Tong, Shuhang Gao, Wenjing Qi, et al.
Journal of Ethnopharmacology|May 7, 2026
Integrative multi-omics reveals that Pueraria thomsonii Radix alleviates dyslipidemia by remodeling gut microbiota and regulating arachidonic acid metabolismDaqian Yin, Meiqing Chen, Xiaofan Chen, et al.
Pageof 10